Valuation: Middle East Pharmaceutical Industries Company

Market Cap 2.08B 555M 479M 451M 410M 770M 53.08B 783M 5.28B 2.06B 26.58B 2.04B 88.34B P/E 2024
30.5x
P/E 2025 22.9x
Enterprise Value 2.11B 563M 486M 457M 416M 781M 53.83B 794M 5.35B 2.09B 26.96B 2.07B 89.59B EV / Sales 2024
6.29x
EV / Sales 2025 4.89x
Free-Float
46.88%
Yield 2024
1.64%
Yield 2025 2.18%
1 day-1.57%
1 week-1.89%
Current month+3.03%
1 month-2.22%
3 months+0.17%
6 months-9.38%
Current year-6.28%
1 week 59.3
Extreme 59.3
62.5
1 month 57.55
Extreme 57.55
62.5
Current year 53.89
Extreme 53.885712
68.51
1 year 53.89
Extreme 53.885712
79.09
3 years 51.54
Extreme 51.542856
112.91
5 years 51.54
Extreme 51.542856
112.91
10 years 51.54
Extreme 51.542856
112.91
Manager TitleAgeSince
Chief Executive Officer 45 2018-09-04
Director of Finance/CFO - 2024-03-10
Chief Tech/Sci/R&D Officer 51 2022-12-31
Director TitleAgeSince
Chairman 54 2022-04-09
Director/Board Member 45 2023-09-12
Director/Board Member 45 2022-04-09
Change 5-day change 1-year change 3-year change Capi.($)
-1.57%-1.89%-15.34% - 564M
-0.10%-0.77%+17.58%+70.16% 48.43B
-3.26%-5.31%+52.47%+116.17% 39.72B
-0.60%-0.94%-7.29%+17.35% 12.25B
-2.75%+1.88%+14.81%+76.92% 11.84B
-0.58%-0.77%+29.90%+135.00% 9.06B
+1.56%+5.52%+23.69%+41.38% 7.57B
+0.52%+2.08%+42.23%-13.09% 7.18B
-0.07%+1.72%+13.39%+190.65% 6.84B
-2.51%-3.14%-30.53%+23.54% 5.77B
Average -0.94%+1.28%+14.09%+73.12% 14.92B
Weighted average by Cap. -1.21%+1.00%+24.67%+80.85%

Financials

2024 2025
Net sales 394M 105M 90.64M 85.17M 77.46M 146M 10.03B 148M 998M 390M 5.03B 385M 16.7B 460M 123M 106M 99.54M 90.53M 170M 11.73B 173M 1.17B 456M 5.87B 450M 19.52B
Net income 79.85M 21.27M 18.37M 17.26M 15.7M 29.51M 2.03B 30M 202M 79.08M 1.02B 78.12M 3.38B 97.01M 25.84M 22.32M 20.97M 19.07M 35.86M 2.47B 36.45M 246M 96.07M 1.24B 94.9M 4.11B
Net Debt 42.83M 11.41M 9.85M 9.26M 8.42M 15.83M 1.09B 16.09M 108M 42.42M 546M 41.9M 1.82B 29.47M 7.85M 6.78M 6.37M 5.79M 10.89M 751M 11.07M 74.65M 29.19M 376M 28.83M 1.25B
Logo Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Employees
731
Date Price Change Volume
26-08-16 SAR 59.55 -1.57% 112,676
26-08-13 SAR 60.50 -0.08% 59,078
26-08-12 SAR 60.55 -0.25% 22,579
26-08-11 SAR 60.70 -1.70% 86,421
26-08-10 SAR 61.75 +0.73% 88,254
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
59.55SAR
Average target price
146.40SAR
Spread / Average Target
+145.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4016 Stock